Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales
Bristol Myers Squibb (NYSE: BMY) today reported second quarter 2026 financial results. Visit the company’s Investor Relations website at http://investor.bms.com ...
Barchart Research What to Expect from BMY Earnings BMY Generated July 29, 2026 Current Price $63.10 EPS Estimate $$1.59 Consensus Rating Moderate Buy Average Move 5.36% Bristol-Myers Squibb: Wall Street's...
/Bristol%20Myers%20Squibb%20logo%20under%20a%20magnifying%20glass_%20By%20Casimiro.jpeg)
Bristol-Myers Squibb has rallied the broader market over the past year, and analysts remain moderately bullish about the stock’s prospects.
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q2 Results Tomorrow
As investors rotate toward value, Altria, Bristol Myers Squibb, and American Electric Power stand out as reliable dividend stocks with strong payout growth histories and defensive appeal.
Expanded collaboration gives BMS the most advanced and most energy-efficient NVIDIA infrastructure in life sciences BMS will deploy NVIDIA DGX Vera Rubin NVL72 systems...
Application based on results from SUCCESSOR-2 trial showing oral CELMoD mezigdomide in combination with carfilzomib and dexamethasone significantly improved progression-free survival vs. standard of care...
Bristol-Myers Squibb is expected to report its second-quarter earnings later this month, and Wall Street is calling for a double-digit decrease in profit.